Pick of the day
Vitalize
A Y Combinator-backed startup building an AI-native operating system that unifies hospital staffing, scheduling, patient flow, and capacity management.
- Problem
- 7
- Traction
- 7
- Founders
- 6
- Market
- 8
- Novelty
- 5
Why today
Today's pick is Vitalize, the San Francisco healthtech startup that announced a 31 million dollar Series A on October 6, 2026, led by Oak HC and FT. The window also included a 50 million dollar Series A for defense-logistics startup Gallatin AI, a 9 million dollar round for Indian B2B edtech startup byteXL, a seed-plus round for Bengaluru agentic AI startup Desible.ai, and a seed round for Indian AI debt-resolution startup Credfix. Vitalize stands out because it already has paying enterprise hospital customers reporting concrete operational gains, not just a product roadmap, and it is tackling labor costs that its own research pegs at roughly half of all US hospital operating expenses, a problem large enough that even modest efficiency gains translate into real savings.
Problem
US hospitals run staffing, scheduling, patient flow, and capacity planning as largely separate, manual processes stitched together with spreadsheets, pagers, and disconnected point solutions. Vitalize says labor accounts for roughly 50 to 60 percent of hospital operating expenses nationally, approaching a trillion dollars a year, yet the systems that decide who works which shift, where, and for how long remain fragmented and reactive. That fragmentation shows up as chronic understaffing in some units, costly premium and contract labor in others, and clinical leaders spending hours a day on manual coordination instead of patient care, a problem that gets worse as hospitals face persistent nursing shortages and tight margins.
Product
Vitalize builds what it calls an AI-native operating system that combines staffing, scheduling, patient flow, and capacity management into a single platform rather than separate tools. The software integrates with hospitals' existing electronic medical record, timekeeping, and payroll systems so it can sit on top of infrastructure that is already in place, and it is designed to support inpatient, procedural, and ambulatory care operations. The pitch to health systems is that unifying these previously siloed functions lets AI models reason across staffing and capacity together, catching problems a single-purpose scheduling tool would miss.
Traction
Vitalize says its platform is now live across dozens of enterprise health systems and manages millions of shifts every week, scale that goes well beyond a pilot deployment. Rochester Regional Health reported cutting the time its staff spends on manual staffing and scheduling tasks by roughly half after adopting the platform, and St. Luke's Health reported a sharp reduction in premium labor spend within weeks of rollout. Vitalize also claims the platform saves clinical leaders more than 2,000 hours a day in aggregate across its customer base, a company-reported figure rather than an independently audited one.
Team
Vitalize went through Y Combinator's Winter 2023 batch and is led by CEO and co-founder Veeraj Shah, alongside co-founders Sanketh Andhavarapu and Nikhil D'Souza. Before Vitalize, Shah co-founded two behavioral health nonprofits and worked on digital health strategy initiatives connected to the US Surgeon General's office and IBM. The company reportedly started out as a healthcare worker wellness app before pivoting to focus squarely on hospital operations, beginning with workforce and capacity management, a shift that put it closer to where hospital budgets actually hurt.
Funding
The 31 million dollar Series A, announced October 6, 2026, was led by Oak HC and FT, with Norwest, .406 Ventures, Constellation Ventures, Y Combinator, Rock Health Capital, and MemorialCare Innovation Fund also participating. Vitalize plans to use the capital to expand its growth and deployment teams and to further develop AI models focused on patient throughput optimization, building on an earlier, smaller round that included Y Combinator, Rebel Fund, Liquid2 Ventures, and healthcare angel investors.
VC lens
Would YC fund it? Yes, on the strength of paying enterprise customers already reporting measurable operational savings, though the platform still competes against entrenched hospital scheduling and staffing vendors with long-standing health system relationships.
Biggest risk: Vitalize's headline results, the hours saved and premium labor cut at named hospitals, are company-reported figures rather than independently audited numbers, and the company must keep proving those gains as it moves from early enterprise wins to broad deployment across health systems with entrenched incumbent scheduling and staffing software.
Runners-up
Gallatin AI
50 million dollar Series A led by 8VC and Silent Ventures for the defense-logistics startup scaling its Navigator platform, already used by US Army and Air Force units for fuel, medical, and munitions supply decisions. (Oct 8)
byteXL
9 million dollar funding round led by Elevar Equity, with Kalaari Capital and the Michael and Susan Dell Foundation also participating, for the Hyderabad B2B edtech startup bringing AI skilling to engineering colleges in India's smaller cities. (Oct 7)
Desible.ai
Roughly 3.3 million dollar seed-plus round led by Prime Venture Partners for the Bengaluru startup building agentic AI tools that automate compliance and workflow tasks for banks, NBFCs, and insurers. (Oct 7)
Credfix
Roughly 1.9 million dollar seed round led by Tanglin Venture Partners for the Indian AI-powered debt-resolution startup supporting borrower outreach and repayment plans. (Oct 8)
Archive
38 reports · click a row to open it| Date | Winner | One-liner | Runners-up | Open |
|---|---|---|---|---|
| 2026-10-19 | Modal Labs | 750 million dollar Series D led by Accel at a 15.75 billion dollar valuation, as the AI infrastructure startup says its annualized run rate crossed 1 billion dollars with usage tripling in five months, built on serverless GPU access for inference, training and agent sandboxes | OMass Therapeutics, Scanntech, North.cloud, Fortem Technologies | |
| 2026-10-18 | Mueon | 65 million dollar Series A led by Maverick Silicon, as the Portland semiconductor startup founded by two Intel veterans scales Cubelets, modular 3D blocks bundling compute, memory, power and cooling to cut AI data center power and density limits, already in use by AI chip startup d-Matrix | Estuary Biotherapeutics, Fission, Otter Health, HyLight | |
| 2026-10-17 | Chariot Claims | 10 million dollar Series A led by Silverton Partners, as the rebranded ClaimClam legal-tech platform scales automated matching of consumers to mass arbitration and class-action claims over hidden fees and hard-to-cancel subscriptions, building on more than 65,000 claims already processed toward an estimated 92 million dollars in settlements | Marklo, Siena, Rein Security, Peppermint | |
| 2026-10-16 | Salience Labs | 125 million dollar oversubscribed Series B led by Bullhound Capital, as the Oxford-spun-out photonics company wins new backing from AMD Ventures and Intel Capital for all-optical circuit switches meant to break the power and latency ceiling facing electronic switches as AI GPU clusters scale toward tens of thousands of chips | Navra, Type One Energy, Oratomic, Gallatin AI | |
| 2026-10-15 | Soufflé Therapeutics | 135 million dollar Series B led by Juvia Group, as the MIT bioengineer Robert Langer-founded biotech works to deliver RNA medicines to muscle and heart tissue, a problem that has stalled the entire siRNA drug class, backed by more than 3.5 billion dollars in big pharma partnerships before any program has reached the clinic | ICON, Pluto Security, Nous Research, Atomic Machines | |
| 2026-10-14 | Vitalize | 31 million dollar Series A led by Oak HC and FT, as the Y Combinator-backed startup unifying hospital staffing, scheduling, patient flow and capacity management expands after enterprise customers reported cutting manual scheduling work and premium labor spend | Gallatin AI, byteXL, Desible.ai, Credfix | |
| 2026-10-13 | Universal Quantum | 100 million dollar Series A co-led by DCVC and Firgun Ventures, a record raise for a UK quantum computing company, as the University of Sussex spinout races to prove its modular trapped-ion chiplet interconnect can out-scale newly public rivals Quantinuum and IonQ | Atlas Atomics, Type One Energy, Sabi, Catalyst | |
| 2026-10-12 | Manus | 500 million dollar funding round led by Boyu Capital and IDG Capital, the general AI agent's first raise since China blocked Meta's 2 billion dollar bid for the company and barred its founders from leaving the country, as Manus pursues a reported 4 billion dollar valuation on roughly 125 million dollars of annualized revenue | Oratomic, Matchpoint Therapeutics, Oxide Computer, Stuut | |
| 2026-10-11 | Arena | 200 million dollar Series B co-led by Lightspeed Venture Partners and Khosla Ventures at a 3.1 billion dollar valuation, as the company behind the Chatbot Arena leaderboard nearly doubles its valuation in ten months on roughly 100 million dollars of annualized revenue from selling AI evaluation and alignment benchmarking to labs and enterprises, while Scale AI's new Seal Showdown contests its neutral-referee position | Gallatin AI, Rein Security, Rivercell, TeddyHoldings.AI | |
| 2026-10-10 | Multiply Labs | 75 million dollar Series B led by Patrick Soon-Shiong's NantWorks with new investors AstraZeneca, Lingotto, Teradyne and Strange Ventures, as the decade-old biologics-manufacturing robotics company passes 100 million dollars raised on the strength of its first commercial sale, an up to 85 million dollar deal with Retro Biosciences, while competing against well-funded rivals Cellares and Ori Biotech to automate cell and gene therapy production | Zomint, Parakeet Health, OuterSignal, Efficient Computer | |
| 2026-10-09 | RougeTx | 58 million dollar Series A led by BioGeneration Ventures and Angelini Ventures with the European Investment Bank's Aurea facility and Kurma Partners also investing, as the Leiden University Medical Center spinout launches the first disease-modifying candidate for hereditary hemorrhagic telangiectasia, a bleeding disorder with no approved therapies, built on more than two decades of pericyte research | GMI Cloud, Varda Space Industries, doxx.net, Beyond Appliances | |
| 2026-10-08 | General Medicine | 120 million dollar Series B led by Andreessen Horowitz with Eli Lilly and Mercy Health joining, as the PillPack founders' online healthcare marketplace brings total funding to 152 million dollars less than three years after launch on hundreds of thousands of customers and an 80 Net Promoter Score | Noah, Nous Research, Buntar Aerospace, Monid | |
| 2026-10-07 | Vinci | 250 million dollar Series B at a 1.5 billion dollar valuation co-led by Advent, Temasek and Xora Innovation, as the Palo Alto physics foundation model startup jumps from a 46 million dollar seed and Series A disclosed last December to a tenfold valuation leap less than a year later, aiming its technology at chip design incumbents Cadence and Synopsys | Spiko, Hadrian, WhiteLab Genomics, Inbolt | |
| 2026-10-06 | Pandektes | 13.5 million euro Series A led by Munich's Alstin Capital, as the Copenhagen legal-research startup grows revenue sixfold and wins customers switching off LexisNexis, Westlaw, Beck and Karnov with an API-first legal data platform | OneByZero, Fleuret AI, Laki Power, RobCo | |
| 2026-10-05 | PaleBlueDot AI | 200 million dollar Series C at a 3.2 billion dollar valuation led by ComputeCore, as the Palo Alto AI compute platform nearly triples its valuation in under nine months on more than 5 billion dollars of signed customer contracts | Simple Energy, Elio Mortgage, Menos AI, SedMed | |
| 2026-10-04 | Flow Engineering | 50 million dollar Series B at a 750 million dollar valuation co-led by Valor Equity Partners and Atreides Management, as the AI-native systems-engineering platform for hardware teams grows to over 100 million requirements managed and adds General Motors, Anduril and Intuitive Machines as customers less than a year after its Series A | Miter, Kanu AI, Beltic, Satlyt | |
| 2026-10-03 | EliseAI | 350 million dollar round at a 4 billion dollar valuation led by Andreessen Horowitz and Bessemer Venture Partners, as the housing and healthcare conversational AI company nearly doubles its valuation in thirteen months on 200 million dollars of ARR and five straight years of 100 percent revenue growth | Kahua, Breye Therapeutics, Amara, Kuro | |
| 2026-10-02 | Armadin | 255.5 million dollar Series B co-led by Andreessen Horowitz and Accel at a 2.5 billion dollar valuation, as Mandiant founder Kevin Mandia's agentic attacker-swarm security platform runs live attack campaigns for Fortune 500 and government customers seven months after stealth | Foundational, Seeds Fincap, Numeral, Chamelio | |
| 2026-10-01 | General Intuition | 220 million dollar Series B at a 6.2 billion dollar valuation, nearly tripling in three months, as the AI foundation model startup trains action models on billions of gameplay clips from its own sister company Medal | Varda, Jeeves, Sand.ai, Arivihan | |
| 2026-09-30 | Tiny Health | Oversubscribed $33M Series B led by B Capital as the at-home microbiome testing company posts 1,624% three-year revenue growth and quadruples its practitioner-facing business | Modulate, erad, Baselayer, Ande | |
| 2026-09-29 | Instinct | $1B Series C led by Sequoia, Benchmark and Coatue at a $10B valuation, a roughly 4x jump in five weeks, as its text-message AI agent passes 100,000 users with 10% daily compounding growth | SiMa.ai, Quartermaster, Outmarket AI, Humanos | |
| 2026-09-28 | Solcoa Industries | $75M seed ($45M equity led by Bain Capital Ventures plus $30M JPMorgan-anchored debt) to build a 500-tonne Nevada plant using a novel rare-earth metalmaking process, aimed at breaking China's 95% grip on metallization | Clastix, Prevision Medicine, Spiich, Barq | |
| 2026-09-27 | Ultraviolette | $85M Series E led by Yali Capital and TDK Ventures; Bengaluru performance EV motorcycle maker plans US entry by 2027 on 4-5x revenue growth | Micro1, Kasvu Therapeutics, HIFI, Dextr AI | |
| 2026-09-26 | Island | $400M Series F led by Evolution Equity Partners at a $6.4B valuation, more than doubling its 2024 valuation as the enterprise browser expands into governing AI agents | Cyera, Confido, Heidi Health, Firecrawl | |
| 2026-09-25 | Ema | $77M Series B led by Creaegis, more than quadrupling its valuation as every existing backer doubled down and Wipro scales its AI Employees to 240,000+ workers | Ando, Kasvu Therapeutics, HIFI, Nuvah | |
| 2026-09-24 | TEKEVER | $580M Series D led by UC Investments and Baillie Gifford; Ukraine-proven AI surveillance drone maker hits $6.4B valuation on a new 400M pound UK Army contract | Enveda Biosciences, Basecamp Research, Numeral, Brahma AI | |
| 2026-09-23 | Verda | $189M oversubscribed Series B led by Emergence Capital; profitable Nordic GPU cloud crosses $1B valuation on $165M ARR | Snorkel AI, Nexstrom, MacroCycle, Demoverse | |
| 2026-09-22 | BCI-Sonics | RMB 200M (~$30M) Pre-Series A led by HSG and Yunqi Capital; non-invasive ultrasound brain-computer interface racing China's invasive BCI leaders and OpenAI-backed Merge Labs | Spott, HighLife, CellPoint, Benford | |
| 2026-09-22 | Amber Electric | €49M Series E led by Morgan Stanley's 1GT; automates 50%+ of Australia's home batteries, expanding VPP software into Europe via E.ON | Corridor, Paymob, Unit1 Studio, Drivn | |
| 2026-09-18 | TypeSafe AI | $40M seed led by DCVC; "System One" model returns typed decisions for software, not chat — built by RLHF co-inventor Diogo Almeida | Space Epoch, Facilo, Treble Technologies, DheyaTech | |
| 2026-09-17 | Exein | $270M Series C at $1.7B valuation (30x in 2 yrs); kernel-level security layer for robots, drones and autonomous machines | Anew Labs, Delos Data, CADDi, AIUC | |
| 2026-09-16 | Euclyd | €200M+ Series A; Samsung-backed (investor + manufacturer) AI inference chip built to out-efficiency Nvidia, chaired by ex-ASML CEO | Profound, Flam, ENCOS, Nutshell Therapeutics | |
| 2026-09-15 | Fortaegis | $50M oversubscribed Series A; quantum-safe security rooted in silicon, chaired by Quantinuum founder Ilyas Khan | Qupital, Tandem Health, Atomarine, UniqYou | |
| 2026-09-11 | Positron AI | $875M Series C at $5B valuation; memory-first inference chips challenging Nvidia's HBM lock-in | The Boring Company, Mach Industries, Rogo Technologies, Swish | |
| 2026-09-10 | Cognition AI | $2B+ Series E at $48B valuation; Devin autonomous coding agent nears $900M run-rate | DigitalPaani, Algomatic Dynamics, Limetax, Fundly.ai | |
| 2026-09-09 | Bluecore Energy | Floating nuclear reactor barges for ports; $50M seed just 2 months after stealth launch | QNu Labs, ARC Ride, Circolife, Hope Care | |
| 2026-09-08 | Pixxel | $100M Series C, India's largest spacetech round; building orbital AI data centers | Nua, Navana.ai, GalaxEye, Atoms (Kalanick) | |
| 2026-09-07 | Medulance | GPS-dispatched ambulance network raises ₹24 Cr Series A-2 | Comet, Mokobara, Kit (Speakeasy), XDOF |
Sources
- Fierce Healthcare — Vitalize Secures $31M to Scale AI-Powered Operating System for Hospital Staffing and Scheduling
- Built In — Healthtech Platform Vitalize Raises $31M Series A
- PYMNTS — Vitalize Secures $31 Million to Address Healthcare's Staffing Chaos
- MobiHealthNews — Vitalize Raises $31M to Tackle Hospital Staffing
- Axios — Exclusive: Gallatin Raises $50M for Futuristic Military Logistics
- Pulse2 — Gallatin AI Raises $50 Million Series A to Expand Military Logistics Platform
- Inc42 — byteXL Raises $9 Mn to Take Tech, AI Skilling to More Engineering Colleges
- DealStreetAsia — India Digest: Desible.ai, Sunfox Tech, byteXL, Zomint Raise Funding
- Inc42 — Desible.ai Raises ₹32 Cr to Build AI Operating Layer for BFSI
- Startup Researcher — Credfix Raises ₹16.1 Crore in Seed Funding
Compiled from search results: article pages were unreachable from the publishing environment on this date, so every fact here was cross-checked against at least two independent reports.